作者
Nithya Kartha, Jessica E Gianopulos, Zachary Schrank, Sarah M Cavender, Stephanie Dobersch, Bryan D Kynnap, Adrianne Wallace-Povirk, Cynthia L Wladyka, Juan F Santana, Jaeseung C Kim, Angela Yu, Caroline M Bridgwater, Kathrin Fuchs, Sarah Dysinger, Aaron E Lampano, Faiyaz Notta, David H Price, Andrew C Hsieh, Sunil R Hingorani, Sita Kugel
发表日期
2023/5/3
期刊
Science translational medicine
卷号
15
期号
694
页码范围
eabn9674
出版商
American Association for the Advancement of Science
简介
Pancreatic ductal adenocarcinoma (PDAC) is classified into two key subtypes, classical and basal, with basal PDAC predicting worse survival. Using in vitro drug assays, genetic manipulation experiments, and in vivo drug studies in human patient-derived xenografts (PDXs) of PDAC, we found that basal PDACs were uniquely sensitive to transcriptional inhibition by targeting cyclin-dependent kinase 7 (CDK7) and CDK9, and this sensitivity was recapitulated in the basal subtype of breast cancer. We showed in cell lines, PDXs, and publicly available patient datasets that basal PDAC was characterized by inactivation of the integrated stress response (ISR), which leads to a higher rate of global mRNA translation. Moreover, we identified the histone deacetylase sirtuin 6 (SIRT6) as a critical regulator of a constitutively active ISR. Using expression analysis, polysome sequencing, immunofluorescence, and …
引用总数